Liabilities / Assets
31st percentile
Higher debt load relative to assets than 31% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.08x
Liabilities / Revenue
45th percentile
Higher debt load relative to revenue than 45% of similar nonprofits.
Net Margin
70th percentile
Higher net margin than 70% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
71st percentile
Faster asset growth than 71% of similar nonprofits.
Revenue Growth
36th percentile
Faster revenue growth than 36% of similar nonprofits.
Balance Sheet
Assets
Up$30,710,295
Up $3,028,372 (+11%) from 2018
Net Assets
Up$28,159,045
Up $2,555,246 (+10.0%) from 2018
Liabilities
Up$2,551,250
Up $473,126 (+23%) from 2018
Revenue And Expenses
Revenue
Down$10,626,839
Down $5,090 (-0.0%) from 2018
Expenses
Up$9,439,199
Up $236,212 (+2.6%) from 2018
Net Income
Down$1,187,640
Down $241,302 (-17%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2018 to Jun 30, 2019
Mission and Program Overview
Mission
The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $30,710,295
- Liabilities
- $2,551,250
- Net assets
- $28,159,045
- Revenue
- $10,626,839
- Expenses
- $9,439,199
- Net income
- $1,187,640